CONFERENCE

March 10, 2020

Today we have received the concerning news from QSPC2020 organizers about the cancellation of the conference in response to COVID-19 outbreak continuation. Quantitative Systems Pharmacology Conference 2020 was planned to be held in April 22-24, 2020 Leiden, The Netherlands. InSysBio team was prepared to present 10 posters

Read more about InSysBio to share the news from QSPC2020 management

13th InSysBio Annual Internal Scientific Meeting

March 3, 2020

26-28 February 2020 InSysBio QSP-company held its 13th Annual Internal Scientific Meeting. InSysBio team presented the results of 2019 year professional progress. Every member demonstrated their personal achievements and shared the plans for the future development. Oleg Demin, InSysBio CEO and founder, summarized all the company’s advancement of the year 2019.

Read more about 13th InSysBio Annual Internal Scientific Meeting

InSysBio to participate in ASCPT 2020

February 19, 2020

InSysBio announced its participation in 121st Annual meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT 2020) which is to be held on March 18-21, 2020 at Marriott Marquis Houston, TX. InSysBio welcomes visitors at the booth # 102. Oleg Demin, CEO of InSysBio, Tatiana Karelina, lead modeler in Alzheimer's Disease and Veronika Musatova, Head of IRT development team, will present the new version of IRT (Immune Response Template) and Cytocon DB (Cell and cYTOkine CONcentrations).

Read more about InSysBio to participate in ASCPT 2020

InSysBio QSP model for BTK inhibitors will be presented at the 61 ASH Annual Meeting

December 3, 2019

QSP model of BTK inhibitors developed by InSysBio in collaboration with BeiGene will be presented as a poster by Srikumar Sahasranaman from Beigene at 61st American Society of Hematology (ASH) Annual Meeting & Exposition. The model describes marketed BTK inhibitors (ibrutinib and acalabrutinib) and zanubrutinib, a BTK inhibitor which recently received accelerated approval from the FDA as a treatment for mantle cell lymphoma (MCL) in adult patients who have received at least one prior therapy.

Read more about InSysBio QSP model for BTK inhibitors will be presented at the 61 ASH Annual Meeting

InSysBio to present at SITC 2019

September 24, 2019

InSysBio announces their participation at 34th Annual Meeting & Pre-Conference Programs on Systems Biology (SITC 2019)

Read more about InSysBio to present at SITC 2019

InSysBio to present at ACoP10

September 18, 2019

InSysBio announces their participation at Tenth American Conference on Pharmacometrics (ACoP10) to be held October 20th to 23rd, 2019, at the Rosen Shingle Creek Hotel in Orlando, FL.

Read more about InSysBio to present at ACoP10

InSysBio to present at PAGE 2019

June 5, 2019

InSysBio announces their participation at PAGE 2019 28th Meeting being held from 11 to 14 June 2019 in Stockholm, Sweden.

Read more about InSysBio to present at PAGE 2019

InSysBio to present at PEGS Boston

March 26, 2019

InSysBio announces their participation at 15th Essential Protein Engineering Summit being held on April 8-12 in Boston, MA.

Read more about InSysBio to present at PEGS Boston

InSysBio to present at AACR Annual Meeting 2019

March 22, 2019

InSysBio announces their participation at American Association for Cancer Research Annual Meeting 2019 being held on March 29 – April 3 in Atlanta, GA

Read more about InSysBio to present at AACR Annual Meeting 2019

12th InSysBio Annual Internal Scientific Meeting

February 28, 2019

20-22 February 2019 InSysBio company held the 12th Annual Internal Scientific Meeting. Results of the last year and plans for the ongoing year were discussed.